Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001174947-24-001019
Filing Date
2024-09-03
Accepted
2024-09-03 08:22:45
Documents
5

Document Format Files

Seq Description Document Type Size
1 FORM SC TO-T/A sctot0924_asahikasei.htm SC TO-T/A 69858
2 PRESS RELEASE DATED SEPTEMBER 2, 2024. sctot0924exa5r_asahika.htm EX-99.(A)(5)(R) 36158
3 ENGLISH VERSION OF PRESS RELEASE DATED SEPTEMBER 3, 2024. sctot0924exa5s_asahika.htm EX-99.(A)(5)(S) 159952
4 GRAPHIC tpress_logo.jpg GRAPHIC 32370
5 GRAPHIC tasahi_logo.jpg GRAPHIC 38319
  Complete submission text file 0001174947-24-001019.txt   365225
Mailing Address 1-105 KANDA JINBOCHO, CHIYODA-KU TOKYO M0 1018101
Business Address 1-105 KANDA JINBOCHO, CHIYODA-KU TOKYO M0 1018101 81 3 3296 3005
Asahi Kasei Corp (Filed by) CIK: 0001446531 (see all company filings)

EIN.: 000000000 | State of Incorp.: M0 | Fiscal Year End: 0331
Type: SC TO-T/A
SIC: 8880 American Depositary Receipts
(CF Office: International Corp Fin)

Mailing Address KUNGSBRON 1, D5 STOCKHOLM V7 SE-111 22
Business Address KUNGSBRON 1, D5 STOCKHOLM V7 SE-111 22 46 8411 3005
Calliditas Therapeutics AB (Subject) CIK: 0001795579 (see all company filings)

EIN.: 000000000 | State of Incorp.: V7 | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-91523 | Film No.: 241272105
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)